metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Applicability of the MASEI index in enthesis and its association with other indi...
Journal Information
Vol. 31. Issue 3.
Pages 349-355 (July - September 2024)
Share
Share
Download PDF
More article options
Visits
1102
Vol. 31. Issue 3.
Pages 349-355 (July - September 2024)
Original Investigation
Applicability of the MASEI index in enthesis and its association with other indices/serological markers of activity in patients with spondyloarthritis
Aplicabilidad del índice entesítico MASEI y su asociación con otros índices/marcadores serológicos de actividad en pacientes con espondiloartritis
Visits
1102
David Castro-Corredora,
Corresponding author
d.castrocorredor@gmail.com

Corresponding author.
, Luis Ángel Calvo Pascualb, Marco Aurelio Ramírez Huarangaa, Marcos Alfredo Paulino Huertasa
a Rheumatology Department, Hospital General Universitario Ciudad Real, Ciudad Real, Spain
b Quantitative Methods Department, Faculty of Economics and Business, Universidad Pontificia de Comillas, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (3)
Table 1. Evaluation of MAdrid Sonographic Enthesitis Index (MASEI).
Table 2. Characteristics of the patients included in the study.
Table 3. MASEI individualized according to enthesitis involvement.
Show moreShow less
Abstract
Introduction

The enthesis is one of the target organs in patients with spondyloarthritis (SpA), since inflammation of it, known as enthesitis, can be observed, which in many patients with spondyloarthritis could go unnoticed.

Objective

To find the relationship between the MASEI index (MAdrid Sonographic Enthesitis Index) in entheses and other indices/serological activity markers (such as BASDAI, DAPSA or ASDAS and ESR, CRP) in spondyloarthritis patients.

Materials and methods

Observational, descriptive, and cross-sectional study. Data were collected from patients with SpA who underwent musculoskeletal ultrasound using the MASEI index and who were treated in our clinics from May 2021 to September 2021. As appropriate, the variables evaluated were described using frequency and central tendency/dispersion measures. First, we tested the normality of all the variables using a Shapiro–Wilk test. Then we studied the correlation of parametric and non-parametric numerical variables, using Pearson's and Spearman's coefficients. We used the T-Student, Mann–Whitney U, and chi-square tests for the categorical variables.

Results

We analyzed 24 patients with SpA (with a mean age of 50.50±10.63 years), 8 women and 16 men. The variables have the following average levels: ASDAS 2.35 (±1.09); BASDAI (for those with axial involvement) 4.54 (±2.93); DAPSA (for psoriatic arthritis) 10.98 (±6.85), and total MASEI 19.88 (±14.77). We found a correlation between the total MASEI and the following variables: ASDAS (Pearson coefficient=.696), BASDAI (Spearman coefficient=.823), and DAPSA (Pearson coefficient=.823).

Conclusion

Patients with spondyloarthritis with more significant disease activity measured by ASDAS, BASDAI/DAPSA, and the serological markers of inflammation CRP and ESR present a higher total MASEI than patients who are controlled.

Keywords:
Ultrasounds
MASEI index
Validation
Spondyloarthritis
Resumen
Introducción

La entesis es uno de los órganos diana en los pacientes con espondiloartritis (EspA), ya que se puede observar una inflamación de esta, conocida como entesitis, que en muchos pacientes con EspA podría pasar desapercibida.

Objetivo

Encontrar la relación entre el índice entesítico MASEI (MAdrid Sonographic Enthesitis Index) y otros índices/marcadores de actividad serológica (como BASDAI, DAPSA, ASDAS, VSG y PCR) en pacientes con EspA.

Materiales y métodos

Estudio observacional, descriptivo y transversal. Se recogieron datos de pacientes con EspA a los que se les realizó ecografía musculoesquelética mediante el índice MASEI y que fueron atendidos en nuestras consultas desde mayo del 2021 hasta septiembre del 2021. Las variables evaluadas se describieron mediante medidas de frecuencia y de tendencia central/dispersión, según correspondía. Primero, probamos la normalidad de todas las variables usando la prueba de Shapiro-Wilk. Luego estudiamos la correlación de variables numéricas paramétricas y no paramétricas, para lo cual utilizamos los coeficientes de Pearson y Spearman. Utilizamos las pruebas T-Student, Mann-Whitney U y chi-cuadrado para las variables categóricas.

Resultados

Se analizaron 24 pacientes con EspA (con una edad media de 50,50±10,63 años), 8 mujeres y 16 hombres. Las variables tienen los siguientes niveles promedio: ASDAS 2,35 (±1,09), BASDAI (para aquellos con afectación axial) 4,54 (±2,93), DAPSA (para artritis psoriásica) 10,98 (±6,85) y MASEI total 19,88 (±14,77). Hemos encontrado correlación entre el MASEI total y las siguientes variables: ASDAS (coeficiente de Pearson=0,696), BASDAI (coeficiente de Spearman=0,823) y DAPSA (coeficiente de Pearson=0,823).

Conclusión

Los pacientes con EspA con mayor actividad de la enfermedad medida por ASDAS, BASDAI/DAPSA y los marcadores serológicos de inflamación PCR y VSG presentan un MASEI total mayor que los pacientes controlados.

Palabras clave:
Ecografía
Índice MASEI
Validación
Espondiloartritis

Article

These are the options to access the full texts of the publication Revista Colombiana de Reumatología
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Quizás le interese:
10.1016/j.rcreu.2020.09.004
No mostrar más